2 weeks Ago By ABMN Staff
Guided Therapeutics, Inc. ( OTCMKTS:GTHP – Get Free Report ) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 9,600 shares, an increase of 146.
2% from the August 31st total of 3,900 shares. Based on an average trading volume of 9,400 shares, the short-interest ratio is currently 1.0 days.
Guided Therapeutics Stock Performance GTHP opened at $0.17 on Friday. The business has a fifty day simple moving average of $0.
13 and a 200 day simple moving average of $0.12. Guided Therapeutics has a 1 year low of $0.
06 and a 1 year high of $0.25. Guided Therapeutics ( OTCMKTS:GTHP – Get Free Report ) last released its quarterly earnings results on Wednesday, August 14th.
The company reported ($0.01) EPS for the quarter. About Guided Therapeutics Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices.
It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. See Also Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter .
.
